SCHEMBL7034253

SCHEMBL7034253

CC(=O)OC[C@@H]1OC(OC(C)=O)[C@H](OC(C)=O)[C@H]1OC(C)=O

nearest known ligand 0.70

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP2D6 P10635 2/20 0.70
THRB P10828 1/20 0.70
HSD17B10 Q99714 1/20 0.70
CA2 P00918 7/20 0.62
TSHR P16473 1/20 0.56
NR3C1 P04150 1/20 0.56
FYN P06241 1/20 0.56
ADRA2A P08913 1/20 0.56
ADORA3 P0DMS8 1/20 0.56
ADRA2B P18089 1/20 0.56
DRD4 P21917 1/20 0.56
DRD3 P35462 1/20 0.56
CA12 O43570 6/20 0.55
CA1 P00915 5/20 0.55
CA9 Q16790 4/20 0.55
LMNA P02545 2/20 0.54
CA4 P22748 2/20 0.51
CA5A P35218 2/20 0.51
CA7 P43166 2/20 0.51
CA5B Q9Y2D0 2/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10056658 1.00 CYP2D6 (0.70) CYP2D6THRBHSD17B10CA2TSHR
SCHEMBL3313146 1.00 CYP2D6 (0.70) CYP2D6THRBHSD17B10CA2TSHR
SCHEMBL7636794 1.00 CYP2D6 (0.70) CYP2D6THRBHSD17B10CA2TSHR
SCHEMBL24584612 1.00 CYP2D6 (0.70) CYP2D6THRBHSD17B10CA2TSHR
SCHEMBL20524278 1.00 CYP2D6 (0.70) CYP2D6THRBHSD17B10CA2TSHR
SCHEMBL23330709 1.00 CYP2D6 (0.70) CYP2D6THRBHSD17B10CA2TSHR
SCHEMBL7034256 1.00 CYP2D6 (0.70) CYP2D6THRBHSD17B10CA2TSHR
SCHEMBL13621664 1.00 CYP2D6 (0.70) CYP2D6THRBHSD17B10CA2TSHR
SCHEMBL7153175 1.00 CYP2D6 (0.70) CYP2D6THRBHSD17B10CA2TSHR
SCHEMBL3312374 1.00 CYP2D6 (0.70) CYP2D6THRBHSD17B10CA2TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2003002586-A1 [4-(4-CYANOBENZOYL)PHENYL]GLYCOFURANOSIDE DERIVATIVES, USE OF SAID DERIVATIVES AS A MEDICAMENT, PRODUCTION METHOD THEREOF AND PHARMACEUTICAL COMPOSITIONS CONTAINING SAME LABORATOIRES FOURNIER SA (FR) 2003-01-09 WO claimed
WO-2003002586-A1 [4-(4-CYANOBENZOYL)PHENYL]GLYCOFURANOSIDE DERIVATIVES, USE OF SAID DERIVATIVES AS A MEDICAMENT, PRODUCTION METHOD THEREOF AND PHARMACEUTICAL COMPOSITIONS CONTAINING SAME LABORATOIRES FOURNIER SA (FR) 2003-01-09 WO disclosed
US-6106872-A HYDROLYSIS OF GLYCOSIDES TO FORM MONOGLYCOSIDES AND ENZYME HYDROLYSIS GIST-BROCADES NV (NL) 2000-08-22 US disclosed
US-5985618-A ENZYMATICALLY HYDROLYZING CIST-BROCADES, N.V. (NL) 1999-11-16 US disclosed
WO-1999051619-A1 ARABINOFURANOSYL BENZIMIDAZOLES AS ANTIVIRAL AGENTS THE REGENTS OF THE UNIVERSITY OF MICHIGAN (US) 1999-10-14 WO disclosed
EP-0416713-B2 Process for obtaining aroma components and aromas from their precursors of a glycosidic nature, and aroma components and aromas thereby obtained DSM NV (NL) 1999-06-23 EP disclosed
US-5573926-A HYDROLYSIS GIST-BROCADES, N.V. (NL) 1996-11-12 US disclosed
EP-0332281-B1 PROCESS FOR OBTAINING AROMA COMPONENTS AND AROMAS FROM THEIR PRECURSORS OF A GLYCOSIDIC NATURE GIST-BROCADES N.V. (NL) 1992-09-23 EP disclosed
WO-1991003174-A1 PROCESS FOR OBTAINING AROMA COMPONENTS AND AROMAS FROM THEIR PRECURSORS OF A GLYCOSIDIC NATURE, AND AROMA COMPONENTS AND AROMAS THEREBY OBTAINED GIST-BROCADES N.V. (NL) 1991-03-21 WO disclosed
EP-0416713-A1 Process for obtaining aroma components and aromas from their precursors of a glycosidic nature, and aroma components and aromas thereby obtained GIST-BROCADES N.V. (NL) 1991-03-13 EP disclosed
EP-0332281-A1 Process for obtaining aroma components and aromas from their precursors of a glycosidic nature GIST-BROCADES N.V. (NL) 1989-09-13 EP disclosed